SCHOTT Pharma AG & Co. KGaA

Research SCHOTT Pharma AG & Co. KGaA (1SXP) on Bullrun: valuation model: 30.1% undervalued, market cap EUR 2.57B, P/E 18.0, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker1SXP
• ExchangeXETRA
• CountryGermany
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyEUR
• Valuation signal30.1% undervalued
• Market capEUR 2.57B
• P/E18.0
• Dividend yield1.1%
• Financial periodQ4 2025
• RevenueEUR 240.19M
• Net incomeEUR 33.18M
• Free cash flow-EUR 20.04M
• Gross margin33.2%

Valuation Snapshot

Bullrun's latest valuation model marks SCHOTT Pharma AG & Co. KGaA as 30.1% undervalued; latest market cap is EUR 2.57B; P/E is 18.0; dividend yield is 1.1%.

About SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments;

Frequently asked questions

Is SCHOTT Pharma AG & Co. KGaA overvalued or undervalued?

Bullrun's valuation model currently marks SCHOTT Pharma AG & Co. KGaA as 30.1% undervalued.

What is SCHOTT Pharma AG & Co. KGaA's market cap?

SCHOTT Pharma AG & Co. KGaA's market capitalization is EUR 2.57B.

What is SCHOTT Pharma AG & Co. KGaA's P/E ratio?

SCHOTT Pharma AG & Co. KGaA's price-to-earnings (P/E) ratio is 18.0.

Does SCHOTT Pharma AG & Co. KGaA pay a dividend?

SCHOTT Pharma AG & Co. KGaA has a dividend yield of 1.1%.

What does SCHOTT Pharma AG & Co. KGaA do?

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics;